ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE (LUPIN LIMITED)
Welcome to the PulseAid listing for the ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE drug offered from LUPIN LIMITED. This Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | LUPIN LIMITED |
| NON-PROPRIETARY NAME: | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE |
| SUBSTANCE NAME: | LAMIVUDINE; ZIDOVUDINE; ABACAVIR SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-12-17 |
| END MARKETING DATE: | 0000-00-00 |
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE HUMAN PRESCRIPTION DRUG Details:
| Item Description | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE from LUPIN LIMITED |
| LABELER NAME: | LUPIN LIMITED |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150; 300; 300(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2013-12-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57297-286_24150f6d-980b-4a8f-bf76-6308c091ed56 |
| PRODUCT NDC: | 57297-286 |
| APPLICATION NUMBER: | ANDA202912 |
Other LAMIVUDINE; ZIDOVUDINE; ABACAVIR SULFATE Pharmaceutical Manufacturers / Labelers:
